Publications#

Martínez-Arranz, I., Mayo, R., Pérez-Cormenzana, M., Mincholé, I., Salazar, L., Alonso, C., & Mato, J. M. (2015). Data in support of enhancing metabolomics research through data mining. Data in Brief, 3, 155–164. https://doi.org/10.1016/j.dib.2015.02.008

Martinez-Arranz, I., Mayo, R., Pérez-Cormenzana, M., Mincholé, I., Salazar, L., Alonso, C., & Mato, J. M. (2015). Enhancing metabolomics research through data mining. J Proteomics, 127(Pt B), 275–288. https://doi.org/10.1016/j.jprot.2015.01.019

Michelena, J., Alonso, C., Martínez-Arranz, I., Altamirano, J., Mayo, R., Sancho-Bru, P., … Caballería, J. (2018). Metabolomics Discloses a New Non-invasive Method for the Diagnosis and Prognosis of Patients with Alcoholic Hepatitis. Annals of Hepatology, 18(1), 144–154. https://doi.org/10.5604/01.3001.0012.7906

Banales, J. M., Iñarrairaegui, M., Arbelaiz, A., Milkiewicz, P., Muntané, J., Muñoz-Bellvis, L., … Macias, R. I. R. (2019). Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis. Hepatology, 70(2), 547–562. https://doi.org/10.1002/hep.30319

Barr, J., Caballería, J., Martínez-Arranz, I., Domínguez-Díez, A., Alonso, C., Muntané, J., … Mato, J. M. (2012). Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J Proteome Res, 11(4), 2521–2532. https://doi.org/10.1021/pr201223p

Martínez-Uña, M., Varela-Rey, M., Cano, A., Fernández-Ares, L., Beraza, N., Aurrekoetxea, I., … Mato, J. M. (2013). Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis. Hepatology, 58(4), 1296–1305. https://doi.org/10.1002/hep.26399

Vazquez-Chantada, M., Gonzalez-Lahera, A., Martinez-Arranz, I., Garcia-Monzon, C., Regueiro, M. M., Garcia-Rodriguez, J. L., … Aransay, A. M. (2013). Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease. Hepatology, 57(2), 505–514. https://doi.org/10.1002/hep.26052

Arbelaiz, A., Azkargorta, M., Krawczyk, M., Santos-Laso, A., Lapitz, A., Perugorria, M. J., … Banales, J. M. (2017). Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma: Extracellular vesicles in PSC, CCA and HCC. Hepatology. https://doi.org/10.1002/hep.29291

Cano, A., Mariño, Z., Millet, O., Martínez-Arranz, I., Navasa, M., Falcón-Pérez, J. M., … Mato, J. M. (2017). A Metabolomics Signature Linked to Liver Fibrosis in the Serum of Transplanted Hepatitis C Patients. Scientific Reports, 7(1), 10497. https://doi.org/10.1038/s41598-017-10807-y

Cubiella, J., Clos-Garcia, M., Alonso, C., Martinez-Arranz, I., Perez-Cormenzana, M., Barrenetxea, Z., … Falcón-Pérez, J. M. (2018). Targeted UPLC-MS Metabolic Analysis of Human Faeces Reveals Novel Low-Invasive Candidate Markers for Colorectal Cancer. Cancers, 10(9). https://doi.org/10.3390/cancers10090300

Mayo, R., Crespo, J., Martínez‐Arranz, I., Banales, J. M., Arias, M., Mincholé, I., … Mato, J. M. (2018). Metabolomic‐based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts. Hepatology Communications, 2(7), 807–820. https://doi.org/10.1002/hep4.1188

Bril, F., Millán, L., Kalavalapalli, S., McPhaul, M. J., Caulfield, M. P., Martinez-Arranz, I., … Cusi, K. (n.d.). Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism, 0(0). https://doi.org/10.1111/dom.13285

Herreros-Villanueva, M., Duran-Sanchon, S., Martín, A. C., Pérez-Palacios, R., Vila-Navarro, E., Marcuello, M., … Arroyo, R. (2019). Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer. Clinical and Translational Gastroenterology, 10(1), e00003. https://doi.org/10.14309/ctg.0000000000000003

Reverter, E., Lozano, J. J., Alonso, C., Berzigotti, A., Seijo, S., Turon, F., … García‐Pagán, J. C. (2019). Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis. Liver International, 39(4), 705–713. https://doi.org/10.1111/liv.14042